Increasing the Usefulness of PROs in Oncology Research

Dr. Anthony Everhart from Signant Health spoke with Professor Tim Meyer, a leading expert in Experimental Cancer Medicine from University College London, about patient-reported outcome measures in cancer research.

The conversation explores the current challenges in measuring patient experiences during clinical trials. Professor Meyer shares insights into the complex process of collecting and interpreting patient data, discussing how current methods often fail to capture the true impact of cancer treatments.

Meyer highlights critical issues in clinical research, including:

• The limitations of existing measurement tools
• Challenges in distinguishing between disease progression and treatment effects
• The importance of capturing patients' real-world experiences

The discussion examines how new technologies and approaches could improve how researchers understand patient experiences. Meyer discusses the potential of remote data collection and more frequent patient assessments to provide a more accurate picture of treatment impacts.

This conversation offers a practical look at the future of cancer research, focusing on ways to better understand and support patients throughout their treatment journey.